Filing Flows › Kewaunee Scientific (KEQU) › Q4 FY26 › vs Q4 FY25
Kewaunee Scientific (KEQU) Q4 FY26 vs Q4 FY25 (year over year)
Kewaunee Scientific's revenue fell $5.7M (-7%) from $77.1M in Q4 FY25 to $71.4M in Q4 FY26. Gross margin 29.8% against 31.2% (-1.4 pts).
Kewaunee Scientific, Q4 FY26: revenue $71.4M (-8% year over year), operating margin 7.3%, net earnings $3.4M, operating cash flow $5.5M. The chart draws each line against Q4 FY25, the increases inside each band.
Margins
| Q4 FY26 | Q4 FY25 | Change | |
|---|---|---|---|
| Gross margin | 29.8% | 31.2% | -1.4 pts |
| Operating margin | 7.3% | 11.0% | -3.7 pts |
| Net margin | 4.7% | 6.3% | -1.5 pts |
| Free cash flow margin | 6.3% | 11.5% | -5.2 pts |
Every line
| Line | Q4 FY26 | Q4 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $71.4M | $77.1M | −$5.7M | -7% |
| Gross profit | $21.2M | $24.0M | −$2.8M | -12% |
| Cost of revenue | $50.2M | $53.1M | −$3.0M | -6% |
| Operating profit | $5.2M | $8.5M | −$3.3M | -39% |
| Operating expenses | $16.0M | $15.5M | $491K | +3% |
| Pre-tax earnings | $4.8M | $7.1M | −$2.4M | -33% |
| Other expense, net | $460K | $1.4M | −$891K | -66% |
| Net earnings | $3.4M | $4.8M | −$1.5M | -30% |
| Minority interests | $304K | $97K | $207K | +213% |
| Income tax | $1.1M | $2.2M | −$1.1M | -52% |
| Depreciation & amortization | $1.6M | $1.6M | −$20K | -1% |
| Share-based compensation | $502K | $370K | $132K | +36% |
| Working capital & other | $15K | $2.6M | −$2.6M | -99% |
| Operating cash flow | $5.5M | $9.4M | −$3.9M | -42% |
| Free cash flow (OCF − capex) | $4.5M | $8.9M | −$4.4M | -49% |
| Capital expenditures | $928K | $516K | $412K | +80% |
Questions
How much did Kewaunee Scientific's revenue grow year over year in Q4 FY26?
Kewaunee Scientific's revenue fell $5.7M (-7%) from $77.1M in Q4 FY25 to $71.4M in Q4 FY26. Gross margin 29.8% against 31.2% (-1.4 pts).